Application of CORO2B protein detection reagent in preparation of ovarian cancer peritoneal metastasis neoadjuvant chemotherapy drug resistance identification reagent

The invention relates to the field of inspection and diagnosis, and particularly discloses application of a CORO2B protein detection reagent in preparation of a reagent for identifying neoadjuvant chemotherapy drug resistance of ovarian cancer peritoneal metastasis. The invention develops a method f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HUANG CANHUA, QIU LIN, FENG JING, LIU CHANG, LANG TINGYUAN, YANG ZHUO, YANG MUYAO
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the field of inspection and diagnosis, and particularly discloses application of a CORO2B protein detection reagent in preparation of a reagent for identifying neoadjuvant chemotherapy drug resistance of ovarian cancer peritoneal metastasis. The invention develops a method for identifying neoadjuvant chemotherapy-resistant ovarian cancer peritoneal metastasis by taking CORO2B as a marker and application thereof by discovering the characteristic of high expression of CORO2B in ovarian cancer peritoneal metastasis tissues after neoadjuvant chemotherapy and ovarian cancer peritoneal metastasis tissues of patients without response to neoadjuvant therapy. The corresponding CORO2B protein detection reagent can be used for preparing a reagent for identifying the neoadjuvant chemotherapy drug resistance of the ovarian cancer peritoneal metastasis. The invention provides a new method and new application for detecting the ovarian cancer peritoneal metastasis drug resistance and preparing an ova